newsImfinzi combination fails advanced lung cancer study22 August 2019 | By Rachael Harper (European Pharmaceutical Review)A late-stage clinical trial for Imfinzi and an experimental treatment has not extended the lives of patients with advanced non-small cell lung cancer.
newsNICE endorses dacomitinib for treatment of lung cancer8 July 2019 | By European Pharmaceutical ReviewVizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
newsDecision by NICE for the use of osimertinib to be appealed7 July 2019 | By European Pharmaceutical ReviewA pharmaceutical company will appeal a decision by NICE to not recommend osimertinib for use within NHS England.
newsDetecting early-stage lung cancer when surgical cure is possible11 October 2018 | By European Pharmaceutical ReviewA method using blood tests could enable clinicians to detect and diagnose early-stage lung cancer in order that surgery could be used as a treatment...
newsDurvalumab improves survival of non-small cell lung cancer patients28 September 2018 | By Iqra Farooq (European Pharmaceutical Review)Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer...
newsPioneering radiotherapy machine treats its first patient in the UK26 September 2018 | By Mike StonesImproved accuracy and fewer patient side effects are among the benefits claimed for the pioneering radiotherapy machine...
newsSaliva diagnostics: Will saliva translate into a real diagnostic tool?1 August 2018 | By Iqra Farooq (European Pharmaceutical Review)Saliva has been used to measure stress hormones, enzyme levels and cancer mutations...
newsWatson system increases clinical trial enrolment by 80 percent12 July 2018 | By European Pharmaceutical ReviewWatson for Clinical Trial Matching, an AI platform, has shown an increase of 80 percent in enrolment for breast cancer clinical trials, along with reduced screening times for patients...
newsBlood test shows potential for early detection of lung cancer4 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)A test that analyses free-floating DNA in the blood may be able to detect early-stage lung cancer...
newsNivolumab reduces size of some lung cancer tumours, relapse rate after surgery16 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)A drug given to early-stage lung cancer patients before they undergo surgery showed major tumour responses in the removed tumour...
newsTwo-drug combination proves effective for most lung cancers6 April 2018 | By European Pharmaceutical ReviewNew study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
newsRNA-based therapy cures lung cancer2 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice...
newsNanoshells could deliver more chemo with fewer side effects9 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)In vitro study verifies method for remotely triggering release of cancer drugs...
newsTarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer25 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues...
newsAlcohol aversion drug disulfiram may combat chemotherapy resistance5 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
